Novel curcumin-based analogues as potential VEGFR2 inhibitors with promising metallic loading nanoparticles: synthesis, biological evaluation, and molecular modelling investigation
RSC Medicinal Chemistry · 2024 · 15 (12) · 4039-4067
DOI: 10.1039/d4md00574k ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Medicinal Chemistry, 2024. Verfasst von Asmaa S A Yassen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Suez Canal University Ismailia 41522 Egypt Asmaa_yaseeen@pharm.suez.edu.eg hossamel…. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 149 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Targeting VEGFR2, compound 4e and its Fe 2 O 3 -humic acid-NPs could be further developed as promising anti-breast cancer agents.
Autor:innen und Institutionen
- Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Suez Canal University Ismailia 41522 Egypt Asmaa_yaseeen@pharm.suez.edu.eg hossameldeen_ahmed@pharm.suez.edu.eg ranza.el-rayes@pharm.suez.edu.eg.
- Department of Medicinal Chemistry, Faculty of Pharmacy, Galala University New Galala 43713 Egypt.
- Pharmaceutical Organic Chemistry Department, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology Giza Egypt sherief.abdalwahab@must.edu.eg Khadeja.attia@must.edu.eg.
- Medicinal Chemistry Department, Faculty of Pharmacy, Suez Canal University Ismailia 41522 Egypt khaled_darwish@pharm.suez.edu.eg.
- Department of Chemistry, College of Sciences, University of Sharjah P.O. 27272 Sharjah United Arab Emirates Mohamed.ElSayed@sharjah.ac.ae.
- Department of Chemistry, Faculty of Science, Suez Canal University Ismailia 41522 Egypt Mohamed_nafie@science.suez.edu.eg.
ORCID-Profile: Asmaa S A Yassen, Khaled M Darwish, Mohamed S Nafie, Reda F A Abdelhameed, Ranza Elrayess
Zitieren
APA
Yassen, A. S. A., Abdel-Wahab, S. M., Darwish, K. M., Nafie, M. S., Abdelhameed, R. F. A., El-Sayyad, G. S., El-Batal, A. I., Attia, K. M., Elshihawy, H. A., & Elrayess, R. (2024). Novel curcumin-based analogues as potential VEGFR2 inhibitors with promising metallic loading nanoparticles: synthesis, biological evaluation, and molecular modelling investigation. RSC Medicinal Chemistry, 15(12), 4039-4067. https://doi.org/10.1039/d4md00574k
Vancouver
Yassen ASA, Abdel-Wahab SM, Darwish KM, Nafie MS, Abdelhameed RFA, El-Sayyad GS, et al. Novel curcumin-based analogues as potential VEGFR2 inhibitors with promising metallic loading nanoparticles: synthesis, biological evaluation, and molecular modelling investigation. RSC Medicinal Chemistry. 2024;15(12):4039-4067. doi:10.1039/d4md00574k
BibTeX
@article{Yassen2024,
author = {Yassen, Asmaa S A and Abdel-Wahab, Sherief M and Darwish, Khaled M and Nafie, Mohamed S and Abdelhameed, Reda F A and El-Sayyad, Gharieb S and El-Batal, Ahmed I and Attia, Khadiga M and Elshihawy, Hosam A and Elrayess, Ranza},
title = {Novel curcumin-based analogues as potential VEGFR2 inhibitors with promising metallic loading nanoparticles: synthesis, biological evaluation, and molecular modelling investigation},
journal = {RSC Medicinal Chemistry},
year = {2024},
volume = {15},
number = {12},
pages = {4039--4067},
doi = {10.1039/d4md00574k}
}
EUVIMED